含合成肽(P-15)生物功能化种植体表面的体内评价及其对骨结合的影响:一项临床前动物研究
该临床前动物研究将机械加工种植体(M组,n=20)、FRIADENT® plus表面种植体(P组,n=20)及含羟基磷灰石与合成15氨基酸肽P-15的生物仿生表面种植体(BP组,n=40)随机植入10只比格犬下颌骨,评估骨结合。结果显示各组种植体均表现高水平骨结合,6个月愈合后BP组在ROI 2/3的骨-种植体接触(BIC)显著优于P组(P=0.002),但早期骨结合阶段含P-15表面未见获益。
要点
- 6个月愈合后BP组ROI 2/3的BIC为73.2±15.6%,显著高于P组的48.3±10.6%(P=0.002)。
- 植入后2天和7天愈合时,各种植体类型在ROI 1/4、2/3及5的BIC均无统计学差异。
- 作者推测表面生物功能化可改善种植体周围骨形成与重塑,但本研究在骨结合早期阶段未确立P-15表面的获益。
核心结论
- 作者推测表面生物功能化可改善种植体周围骨形成与重塑,从而增加骨-种植体接触。
- 但在本研究设定的局限内,含P-15表面的牙种植体在骨结合早期阶段未确立获益。
研究设计与样本
- 临床前动物研究,将三种改良ANKYLOS® C/X种植体随机植入10只比格犬下颌骨,拔牙后4个月植入(P1-P4)。
- 种植体分组:机械加工种植体为阴性对照(M,n=20),FRIADENT® plus表面(喷砂酸蚀)为阳性对照(P,n=20),含羟基磷灰石与合成15氨基酸肽P-15的生物仿生表面为BP组(n=40)。
- 3只动物分别于植入后2天和7天处死,4只动物于植入后6个月处死。
- 通过组织形态计量学在5个不同感兴趣区(ROI)分析骨-种植体接触(BIC):种植体中段两侧各一(ROI 1/4)、种植体根尖部两侧各一(ROI 2/3)、种植体尖端一处(ROI 5)。
主要发现
- 所有种植体表面均显示高水平骨结合与骨传导性。
- 累积种植体存活率(CSR)为93.8%,其中M组100%、P组85%、BP组95%。
- 植入后2天和7天愈合时,各种植体类型在ROI 1/4、2/3及5的BIC均无统计学差异。
- 所有组的BIC值随时间增加。
- 6个月愈合后,BP组在ROI 2/3的BIC为73.2±15.6%,P组为48.3±10.6%,M组为66.3±30.2%,BP与P组间差异显著(P=0.002)。
关键数值与推荐
- BP组6个月愈合后ROI 2/3的BIC为73.2±15.6%,P组为48.3±10.6%,M组为66.3±30.2%,BP与P组间P=0.002。
- 累积种植体存活率(CSR)为93.8%,M组100%、P组85%、BP组95%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文在结论中写明在本研究设定的局限内,含P-15表面的牙种植体在骨结合早期阶段未确立获益。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The overall aim of the study was to investigate a biofunctionalized implant surface with electrochemically deposition of hydroxyapatite and the synthetic peptide (P-15) and its effect on osseointegration. MATERIAL AND METHODS: Three modified implant types of ANKYLOS® C/X implants were used; (1) machined implants used as negative control (M, n = 20), (2) implants with the FRIADENT® plus surface (grit blasted and acid-etched) used as positive control (P, n = 20), and (3) implants with a biomimetic surface consisting of hydroxyapatite and the synthetic 15 aminoacids containing peptide P-15 (BP, n = 40). The implants were randomly inserted in the mandibles of 10 beagle dogs following 4 months after tooth extraction (P1-P4). Three animals were sacrificed 2 and 7 days after implant insertion, respectively, and four animals were sacrificed 6 months post implant insertion. Bone-to-implant contacts (BICs) were analyzed via histomorphometrical analyses at five different region of interests (ROIs); two at the middle part on either side of the implant (ROI 1/4), two at the apical part of the implant at each side (ROI 2/3), and one at the tip of the implant (ROI 5). RESULTS: All implant surfaces showed a high level of osseointegration and osteoconductivity. The cumulative implant survival rate (CSR) was 93.8%, 100% in the M, 85% in the P, and 95% in the BP group. No statistical difference in BICs at ROI 1/4, 2/3, and 5 could be shown between implant types following 2 and 7 days of healing. BIC values increased in all groups over time. After 6 months of healing the BP group showed superiority in BIC in ROI 2/3 (73.2 ± 15.6%) compared to the P (48.3 ± 10.6%) and M group (66.3 ± 30.2%) with a significant difference between BP and P (P = 0.002). CONCLUSION: It is hypothesized, that the surface biofunctionalization improves peri-implant bone formation and remodeling, leading to an increased bone-to implant contact. However, within the limitations of the study set-up no benefit in the early phase of osseointegration could be established for dental implants with P-15 containing surface in this study.
引用
- Schmitt CM, Koepple M, Moest T, et al. In vivo evaluation of biofunctionalized implant surfaces with a synthetic peptide (P-15) and its impact on osseointegration. A preclinical animal study. Clin Oral Implants Res. 2015. PMID: 26567087. doi:10.1111/clr.12723
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。